Chung-Chin Wu

This inventor holds 6 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Sbc Virbac Limited., Sbc Virbac Biotech Co., Ltd., Dynavax Technologies Corporation. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chung-Chin Wu. Retrieved from https://idiyas.com/inventor/chung-chin-wu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

Wujie Township, I-Lan County, TW (2015)
I-Lan County, TW (2014 - 2017)

Company Filing History:

Sbc Virbac Biotech Co., Ltd.

patents

1 out of 66

Dynavax Technologies Corporation

patents

4. 1 out of 1

Medigen Vaccine Biologics Corporation

patent

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12296002 - Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (2025-05-13),

2. 9770501 - Porcine circovirus type 2 (PCV2), immunogenic composition containing the same, test kit, and application thereof (2017-09-26),

3. 9101571 - Porcine circovirus type 2 (PCV2), immunogenic composition containing the same, test kit, and application thereof (2015-08-11),

4. 9029522 - Recombinant fusion interferon for animals (2015-05-12),

5. 8956623 - Recombinant fusion interferon for animals (2015-02-17),

6. 8784834 - Recombinant fusion interferon for animals (2014-07-22),

Title: Innovations and Contributions of Inventor Chung-Chin Wu

Introduction

Chung-Chin Wu is a notable inventor based in I-Lan County, Taiwan. He has made significant contributions to the field of immunology, particularly in the development of compositions aimed at combating viral infections. With a total of 6 patents to his name, his work has garnered attention in both academic and commercial sectors.

Latest Patents

One of his latest patents is an immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This invention focuses on a recombinant SARS-CoV-2 S protein combined with an adjuvant to enhance immune response. Another significant patent involves a novel porcine circovirus type 2 (PCV2) strain, which includes immunogenic compositions and test kits for its application. These innovations reflect his commitment to addressing pressing health challenges.

Career Highlights

Chung-Chin Wu has worked with Sbc Virbac Limited and Sbc Virbac Biotech Co., Ltd., where he has contributed to various research and development projects. His expertise in immunogenic compositions has positioned him as a key player in the biotechnology sector.

Collaborations

Throughout his career, Chung-Chin Wu has collaborated with notable professionals, including Tsun-Yung Kuo and Han-Ting Chen. These partnerships have facilitated the advancement of his research and the successful development of his patents.

Conclusion

Chung-Chin Wu's innovative work in immunology and his contributions to the development of effective viral compositions highlight his importance as an inventor. His patents not only showcase his expertise but also reflect his dedication to improving public health through scientific advancements.

Profile summary based on public USPTO records.